Cambridge Innovation Capital
Venture capital firm based in Cambridge, UK
Latest Cambridge Innovation Capital investments
Cambridge Innovation Capital has invested in these startups.
BeyondMath
BeyondMath secures seed funding to run simulations in seconds with generative physics. Read more
Nuclera
£8.9m extension enables end-to-end antibody expression and validation on benchtop microfluidics. Read more
T-Therapeutics
Series A rises to £69.3m as T-Therapeutics advances TCR bispecifics to clinic. Read more
Cambridge GaN Devices
Cambridge GaN Devices secures $32M funding to drive energy-efficient innovations, set to impact electric vehicles and data centres. Read more
Forefront RF
Forefront RF just snagged £16 million in funding to propel its revolutionary semiconductor technology, setting the stage to transform the next generation of multi-band smartphones and smartwatches. Read more
Epitopea
Epitopea secures a £500K grant to revolutionize cancer treatment with cutting-edge immunotherapies targeting hidden antigens—ushering in a new era in the fight against cancer. Read more
Riverlane
Riverlane scores a game-changing $75 million Series C funding to revolutionize quantum computing and tackle errors head-on, aiming for a future where one million operations run error-free by 2026. Read more
Investments By Sector
Cambridge Innovation Capital has invested in these sectors
| Biotech | 43.8% |
| Hardware | 37.5% |
| Medical Technology | 6.3% |
| AI | 6.3% |
| Healthtech | 6.3% |
